The Texas Alzheimer’s Research and Care Consortium (TARCC) is a collaboration between ten of the state’s leading medical research institutions, working to improve early diagnosis, treatment, and prevention of Alzheimer’s disease.
Alzheimer's Facts
1 in 9 people age 65+ has Alzheimer's disease.
About 490,000 Texans are projected to have Alzheimer's by 2025.
Every 66 seconds, someone in the United States develops Alzheimer’s.
Get Involved
Legislative Corner
Save the Date — January 23, 2025:
TARCC 2025 Scientific Symposium
Join us on Thursday, January 23, 2025 at the AT&T Executive Hotel and Conference Center for the TARCC 2025 Scientific Symposium. Details to follow...
February 8, 2024: TARCC 2024 Scientific Symposium
Advances in Alzheimer’s Disease Science, Research, and Care
Research poster awards have been announced - read more here.
Now Open: Request for Applications
TARCC is now pleased to announce its 2023 Request for Applications (RFA) as part of a research program to support an innovative, translational-based research structure across the state of Texas, and to ensure that a diverse pool of well-trained basic and translational researchers, and clinician-scientists are available in Texas to aid in the fight against Alzheimer’s disease and related disorders.
Learn more about funding priorities, grant opportunities and how to apply here.
TARCC Research Updates
TARCC investigators have been involved in a number of new, important research studies. Recently published research is wide ranging, spanning the gamut from clinical trials to new cognitive diagnostics; blood-based biomarkers in Mexican-Americans; identification of additional risk genes; and validation of biomarker algorithms in AD patients and AD animal models.
View all TARCC researcher publications here.
View all TARCC Investigator Grant Awards here.